Pfizer beats back generic competition for Lyrica
February 06, 2014 at 13:01 PM EST
WASHINGTON, Feb 6 (Reuters) - Pfizer Inc, the world's largest drugmaker, has beaten back generic competition for the pain medicine Lyrica, its biggest product, with a U.S. appeals court ruling that competing generic products would infringe on the company's patents.
